Mustafa Diken
17Patents
5h-index
35Co-inventors
62Inventor score
Filing activity: May 23, 2012 → Sep 12, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10738355B2 | Individualized vaccines for cancer | Emerging Cross-Sectional Technologies | 35 | Active |
| US10717982B2 | Stabilization of poly(A) sequence encoding DNA sequences | Chemistry; Metallurgy | 12 | Active |
| US10485884B2 | RNA formulation for immunotherapy | Emerging Cross-Sectional Technologies | 8 | Active |
| US10576146B2 | Particles comprising a shell with RNA | Chemistry; Metallurgy | 6 | Active |
| US9950065B2 | Particles comprising a shell with RNA | Chemistry; Metallurgy | 6 | Active |
| US11248264B2 | Individualized vaccines for cancer | Emerging Cross-Sectional Technologies | 2 | Active |
| US11559587B2 | RNA formulation for immunotherapy | Emerging Cross-Sectional Technologies | 1 | Active |
| US12168051B2 | Methods and compositions for stimulating immune response | Chemistry; Metallurgy | 0 | Active |
| US11045418B2 | Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell | Emerging Cross-Sectional Technologies | 0 | Active |
| US11471522B2 | Methods and compositions for stimulating immune response | Chemistry; Metallurgy | 0 | Active |
| US10669322B2 | RNA molecules encoding cytokine fusion proteins and methods of use thereof | Chemistry; Metallurgy | 0 | Active |
| US11701413B2 | RNA for treatment of autoimmune diseases | Chemistry; Metallurgy | 0 | Active |
| US12054723B2 | Stabilization of poly(A) sequence encoding DNA sequences | Chemistry; Metallurgy | 0 | Active |
| US11337922B2 | Lipid particle formulations for delivery of RNA and water-soluble therapeutically effective compounds to a target cell | Emerging Cross-Sectional Technologies | 0 | Active |
| US11660338B2 | Particles comprising a shell with RNA | Chemistry; Metallurgy | 0 | Active |
| US12150947B2 | Formulation for administration of RNA | Human Necessities | 0 | Active |
| US11318195B2 | Formulation for administration of RNA | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.